Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells (Q41505590)
Jump to navigation
Jump to search
scientific article published on May 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells |
scientific article published on May 1997 |
Statements
1 reference
Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells (English)
1 reference
Vile RG
1 reference
Diaz RM
1 reference
Castleden S
1 reference
Chong H
1 reference
1 May 1997
1 reference
1 reference
25
1 reference
2
1 reference
717-722
1 reference
Identifiers
1 reference
1 reference